NAICS 424210: Drugs and Druggists
This industry comprises establishments primarily engaged in the merchant wholesale distribution of biological and medical products; botanical drugs and herbs; and pharmaceutical products intended for internal and/or external consumption in such forms as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.

Illustrative Examples:

Antibiotics merchant wholesalers
Endocrine substances merchant wholesalers
Blood derivatives merchant wholesalers
In-vitro and in-vivo diagnostics merchant wholesalers
Drugs merchant wholesalers
Botanicals merchant wholesalers
Vaccines merchant wholesalers
Cosmetics merchant wholesalers
Vitamins merchant wholesalers
Veterinarians' medicines merchant wholesalers

ExioML sector: Wholesale trade and commission trade services, except of motor vehicles and motorcycles (51)
Region: US | Year: 2022
Sector value added: 810352.883944 M EUR | Employment: 3730.44587599 thousand persons
Sector GHG emissions: 6107301971.21 kg CO2 eq | Energy carrier net total: 113230.446126 TJ | Carbon intensity: 0.007536595589671585

Company: Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals Inc. develops, manufactures, and markets pharmaceutical products. The Company offers products for prevention of infectious diseases, cancer, depression, cardiovascular, and gastrointestinal diseases.